<DOC>
	<DOC>NCT02183285</DOC>
	<brief_summary>To determine the tolerability and safety of Pharmaton PHL 00747 soft gelatine capsules and film-coated tablets</brief_summary>
	<brief_title>Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential</brief_title>
	<detailed_description />
	<criteria>Healthy female outpatients of childbearing potential Ages ranging between 18 and 40 years Willing and able to give written informed consent in accordance to Good Clinical Practice (GCP) and local legislation prior to participation in the study Contraindications to the use of any of the trial ingredients Known hypersensitivity to any of the ingredients Alcohol or drugaddiction Currently participation in another trial, or has participated in a trial within the previous 30 days Known abnormal values of the laboratory tests (if detected after enrolment, subjects will continue the treatment provided there are no medical objections) Already taking other multvitamin products during the last 2 weeks</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>